Noxopharm Files Septic Shock Treatment Patent for Veyonda®
SYDNEY - (BUSINESS WIRE) - Australian drug development company Noxopharm Limited (ASX: NOX) in the clinical stage has…
Browsing Tag
Veyonda
Noxopharm applies to patent Veyonda in septic shock treatment
Australian clinical-stage drug development company Noxopharm (ASX: NOX) announced the filing of an international patent…
Noxopharm (ASX:NOX) submits Veyonda patent for septic shock opportunity
Noxopharm (ASX: NOX) files Veyonda patent for the possibility of septic shock - The Market Herald…
Noxopharm Ltd files patent for Veyonda® as treatment for septic shock
Compelling preclinical COVID-19 data showed that idronoxil, the active ingredient in Veyonda, is effective in stopping cytokines…